46866 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 02
13:53 UTC
|
NIO
NIO
|
↓ Downgrade | firm only | Overweight→ Neutral | $4.50 |
|
Sep 02
13:53 UTC
|
KNF
Knife River
|
↓ Downgrade | Adrian Huerta ★★★☆☆ #2148 | Neutral→ Underweight | $73.00 |
|
Sep 02
13:53 UTC
|
EYPT
Eyepoint Pharmaceuticals
|
↓ Downgrade | Tara Bancroft ★☆☆☆☆ #2967 | Buy→ Hold | $20.00→ $4.00-80.0% |
|
Sep 02
13:53 UTC
|
BCS
Barclays
|
↓ Downgrade | firm only | Overweight→ Equal Weight | |
|
Sep 02
13:53 UTC
|
AMRZ
Amrize
|
↓ Downgrade | firm only | Overweight→ Neutral | $52.00 |
|
Sep 02
13:53 UTC
|
SIRI
Sirius XM
|
↑ Upgrade | Bryan Kraft ★★☆☆☆ #2902 | Hold→ Buy | $31.00→ $45.00+45.2% |
|
Sep 02
13:53 UTC
|
OGE
OGE Energy
|
↑ Upgrade | Stephen D'Ambrisi ★★★☆☆ #1491 | Sec→ r Perform ➝ Outperform | $50.00→ $54.00+8.0% |
|
Sep 02
13:53 UTC
|
NWG
NatWest Group
|
↑ Upgrade | firm only | Equal Weight→ Overweight | |
|
Sep 02
13:53 UTC
|
MTDR
Matador Resources
|
↑ Upgrade | Noah Hungness ★★★☆☆ #1054 | Equal Weight→ Overweight | $79.00→ $77.00-2.5% |
|
Sep 02
13:53 UTC
|
MLM
Martin Marietta Materials
|
↑ Upgrade | Adrian Heurta not yet tracked | Neutral→ Overweight | $680.00 |
|
Sep 02
13:53 UTC
|
ING
ING Group
|
↑ Upgrade | firm only | Equal Weight→ Overweight | |
|
Sep 02
13:53 UTC
|
IHG
Intercontinental Hotels Group
|
↑ Upgrade | firm only | Neutral→ Buy | $188.00 |
|
Sep 02
12:53 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Catharine Trebnick ★★★★☆ #372 | Buy | $355.00→ $415.00+16.9% |
|
Sep 02
12:53 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Gray Powell ★★★★★ #13 | Buy | $380.00→ $404.00+6.3% |
|
Sep 02
12:53 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Shyam Patil ★★★★☆ #838 | Positive | $350.00→ $415.00+18.6% |
|
Sep 02
12:53 UTC
|
NAVN
Navan
|
◎ Target | Nafeesa Gupta ★★★☆☆ #1442 | Buy | $26.00→ $34.00+30.8% |
|
Sep 02
12:53 UTC
|
MMED
MiniMed Group
|
◎ Target | Travis Steed ★★★★☆ #742 | Buy | $24.00→ $28.00+16.7% |
|
Sep 02
12:53 UTC
|
MDT
Medtronic
|
◎ Target | Rick Wise ★★★★★ #162 | Hold | $80.00→ $95.00+18.8% |
|
Sep 02
12:53 UTC
|
MDT
Medtronic
|
◎ Target | David Rescott ★★★★☆ #516 | Neutral | $91.00→ $100.00+9.9% |
|
Sep 02
12:53 UTC
|
MDT
Medtronic
|
◎ Target | Bob Hopkins not yet tracked | Buy | $95.00→ $110.00+15.8% |
|
Sep 02
12:53 UTC
|
MDB
MongoDB
|
◎ Target | Sanjit Singh ★★★★☆ #485 | Overweight | $380.00→ $430.00+13.2% |
|
Sep 02
12:53 UTC
|
MDB
MongoDB
|
◎ Target | Blair Abernethy ★★★★★ #251 | Buy | $395.00→ $445.00+12.7% |
|
Sep 02
12:53 UTC
|
MDB
MongoDB
|
◎ Target | Brad Reback ★★★★☆ #640 | Buy | $475.00→ $465.00-2.1% |
|
Sep 02
12:53 UTC
|
IRON
Disc Medicine
|
◎ Target | David Nierengarten ★★☆☆☆ #2480 | Outperform | $88.00→ $100.00+13.6% |
|
Sep 02
12:53 UTC
|
GWRE
Guidewire Software
|
◎ Target | Allan Verkhovski ★★★★☆ #464 | Buy | $175.00→ $230.00+31.4% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Mike Cikos ★★★★★ #11 | Buy | $38.00→ $65.00+71.1% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Shrenik Kothari ★★★★★ #10 | Outperform | $47.00→ $59.00+25.5% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Koji Ikeda ★★★★☆ #660 | Neutral | $45.00→ $54.00+20.0% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Blair Abernethy ★★★★★ #251 | Buy | $43.00→ $55.00+27.9% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Sanjit Singh ★★★★☆ #485 | Equal Weight | $30.00→ $57.00+90.0% |
|
Sep 02
12:53 UTC
|
GTLB
GitLab
|
◎ Target | Rob Owens ★★★★★ #3 | Neutral | $28.00→ $52.00+85.7% |
|
Sep 02
12:53 UTC
|
DOCU
Docusign
|
◎ Target | Allan Verkhovski ★★★★☆ #464 | Buy | $60.00→ $75.00+25.0% |
|
Sep 02
12:53 UTC
|
DELL
Dell Technologies
|
◎ Target | Erik Woodring ★★★☆☆ #1439 | Equal Weight | $434.00→ $499.00+15.0% |
|
Sep 02
12:53 UTC
|
CRM
Salesforce
|
◎ Target | Matthew VanVliet ★★★★★ #187 | Overweight | $250.00→ $300.00+20.0% |
|
Sep 02
12:53 UTC
|
CRDO
Credo Technology Group
|
◎ Target | Mike Genovese not yet tracked | Neutral | $215.00→ $235.00+9.3% |
|
Sep 02
12:53 UTC
|
CRDO
Credo Technology Group
|
◎ Target | Vivek Arya ★★☆☆☆ #2722 | Buy | $340.00→ $275.00-19.1% |
|
Sep 02
12:53 UTC
|
CLMT
Calumet
|
◎ Target | Amit Dayal ★☆☆☆☆ #3170 | Buy | $60.00→ $75.00+25.0% |
|
Sep 02
12:53 UTC
|
CART
Maplebear
|
◎ Target | Taylor Conrad ★★★★☆ #401 | Buy | $50.00→ $58.00+16.0% |
|
Sep 02
12:53 UTC
|
ATRC
AtriCure
|
◎ Target | Mike Matson not yet tracked | Buy | $45.00→ $64.00+42.2% |
|
Sep 02
12:53 UTC
|
ALMS
Alumis
|
◎ Target | Terence Flynn ★★★★☆ #893 | Overweight | $39.00→ $29.00-25.6% |
|
Sep 02
12:53 UTC
|
TOST
Toast
|
↓ Downgrade | Thomas Poutrieux not yet tracked | Outperform→ Neutral | $38.00→ $35.00-7.9% |
|
Sep 02
12:53 UTC
|
BZLFY
Bunzl
|
↓ Downgrade | firm only | Market Perform | |
|
Sep 02
12:53 UTC
|
SIRI
Sirius XM
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Sep 02
12:53 UTC
|
ALMS
Alumis
|
↑ Upgrade | Mitchell S. Kapoor not yet tracked | Neutral→ Buy | $25.00→ $15.00-40.0% |
|
Sep 02
11:53 UTC
|
TOST
Toast
|
↓ Downgrade | firm only | Outperform→ Neutral | $35.00 |
|
Sep 02
10:52 UTC
|
TOST
Toast
|
↓ Downgrade | firm only | Outperform→ Neutral | |
|
Sep 02
10:52 UTC
|
RBGLY
Reckitt Benckiser Group
|
↓ Downgrade | firm only | Neutral | |
|
Sep 02
10:52 UTC
|
PSO
Pearson
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Sep 02
10:52 UTC
|
PANW
Palo Alto Networks
|
↓ Downgrade | Patrick Colville ★★★★★ #28 | Sec→ r Outperform ➝ Hold | |
|
Sep 02
10:52 UTC
|
IREN
IREN
|
↓ Downgrade | firm only | Buy |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.